Complement component 4, or C4, plays a central role in the complement system. C4d is the final proteolytic remnant of deposited C4b on endothelium and remains covalently attached to endothelium for little more than a week. It is easily detectable by Immunohistochemistry. This antibody combined with anti-C3d can be utilized as a tool for diagnosis of AR (Acute Rejection) and warrant prompt and aggressive anti-rejection treatment. C4d can be detected in peritubular capillaries in both chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival and is an aid in treating acute rejection.
Clone
C4D204
Isotype
IgG1k
Host species
Mouse
Species Reactivity
Human
Cellular Localization
intracytoplasmic vacuoles of endothelial cells, secreted
Positive Control
acute rejected kidney transplant
Applications
ICC/IF, IHC
Intended Use
Research Use Only